Controlled-release injectable microemulsions: recent advances and potential opportunities

Bibliography

• Fraile RJ, Baker LH, Buroker TR, et al. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 1980;40:2223-8
   PubMed Web of Science ®Google Scholar
• Surrey ES, Silverberg KM, Surrey MW, et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 2002;78:699-704
   PubMed Web of Science ®Google Scholar
• Carel JC, Lahlou N, Jaramillo O, et al. Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). J Clin Endocrinol Metab 2002;87:4111-16
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Haukka J, Taylor M, et al. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011;168:603-9
   PubMed Web of Science ®Google Scholar
• Zhornitsky S, Stip E. Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: a systematic review. Schizophr Res Treatment 2012;2012:1-12
   Google Scholar
• Sheehan JJ, Reilly KR, Fu D-J, et al. Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents. Innov Clin Neurosci 2012;9:17-23
   PubMedGoogle Scholar
• Kapitza C, Zijlstra E, Heinemann L, et al. Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care 2010;33:1288-90
   PubMed Web of Science ®Google Scholar
• Adamson L, Curry SH, Bridges PK, et al. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine. Dis Nerv Syst 1973;34:181-91
   PubMedGoogle Scholar
• Gilchrist SE, Rickard DL, Letchford K, et al. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres. Mol Pharm 2012;9:1489-501
   PubMed Web of Science ®Google Scholar
• Rozema FR, Bos RR, Boering G, et al. The effects of different steam-sterilization programs on material properties of poly(L-lactide). J Appl Biomater 1991;2:23-8
   PubMedGoogle Scholar
• Kikuchi H, Carlsson A, Yachi K, et al. Possibility of heat sterilization of liposomes. Chem Pharm Bull (Tokyo) 1991;39:1018-22
   PubMed Web of Science ®Google Scholar
• Montanari L, Costantini M, Signoretti EC, et al. Gamma irradiation effects on poly(dl-lactictide-co-glycolide) microspheres. J Control Release 1998;56:219-29
   PubMed Web of Science ®Google Scholar
• Piskin E. Biodegradable polymers as biomaterials. J Biomater Sci 1994;6:775-95
   Web of Science ®Google Scholar
• Burgess DJ, Hussain AS, Ingallinera TS, et al. Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS PharmSci 2002;4:13-23
   Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89-121
   PubMed Web of Science ®Google Scholar
• Karasulu HY. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity. Expert Opin Drug Deliv 2008;5:119-35
   PubMed Web of Science ®Google Scholar
• Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 1999;16:461-521
   PubMed Web of Science ®Google Scholar
• McClements DJ. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 2012;8:1719-29
   Web of Science ®Google Scholar
• Fanun M. Colloids in Biotechnology, surfactant science series. Volume 152 CRC press, Taylor & Francis group; Florida: 2011
   Google Scholar
• Bagwe RP, Kanicky JR, Palla BJ, et al. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 2001;18:77-140
   PubMed Web of Science ®Google Scholar
• Prince LM. Emulsion and emulsion technology, Part I. Marcel Dekker Inc; New York: 1974
   Google Scholar
• Ke WT, Lin SY, Ho H-O, et al. Physical characterization of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate(TPGS) as a surfactant for the oral delivery of protein drugs. J Control Release 2005;102:489-507
   PubMed Web of Science ®Google Scholar
• Ottinger I. Microemulsion preconcentrate comprising a renin inhibitor. WO058291; 2005
   Google Scholar
• Li G, Fan Y, Li X, et al. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. Int J Pharm 2012;425:53-61
   PubMed Web of Science ®Google Scholar
• Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technolo Today 1999;4:134-43
   PubMedGoogle Scholar
• Li G, Fanb Y, Li X, et al. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. Int J Pharm 2012;425:53-61
   PubMed Web of Science ®Google Scholar
• Schulz MB, Daniels R. Hydroxypropylmethylcellulose (HPMC) as emulsifier for submicron emulsions: influence of molecular weight and substitution type on the droplet size after high-pressure homogenization. Eur J Pharm Biopharm 2000;49:231-6
   PubMed Web of Science ®Google Scholar
• Darole PS, Hegde DD, Nair HA. Formulation and evaluation of microemulsion based delivery system for amphotericin B. AAPS PharmSciTech 2008;9:122-8
   PubMed Web of Science ®Google Scholar
• Borhade VB, Nair HA, Hegde DD. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration. Drug Dev Ind Pharm 2009;35:619-30
   PubMed Web of Science ®Google Scholar
• Djordjevic L, Primorac M, Stupar M, et al. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int J Pharm 2004;271:11-19
   PubMed Web of Science ®Google Scholar
• Djordjevic L, Primorac M, Stupar M. In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions. Int J Pharm 2005;296:73-9
   PubMed Web of Science ®Google Scholar
• Podlogar F, Bester Rogac M, Gasperlin M. The effect of internal structure of selected water-Tween 40-Imwitor 308-IPM microemulsions on ketoprofene release. Int J Pharm 2005;302:68-77
   PubMed Web of Science ®Google Scholar
• Koga K, Nishimon Y, Ueta H, et al. Utility of nano-sized, water-in-oil emulsion as a sustained release formulation of glycyrrhizin. Biol Pharm Bull 2011;34:300-5
   PubMed Web of Science ®Google Scholar
• Washington C, Evans K. Release rate measurements of model hydrophobic solutes from submicron triglyceride emulsion. J Control Release 1995;33:383-90
   Web of Science ®Google Scholar
• Formariz TP, Chiavacci LA, Sarmento VH, et al. Relationship between structural features and in vitro release of doxorubicin from biocompatible anionic microemulsion. Colloids Surf B Biointerfaces 2007;60:28-35
   PubMed Web of Science ®Google Scholar
• Montenegro L, Carbone C, Condorelli G, et al. Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content. Drug Dev Ind Pharm 2006;32:539-48
   PubMed Web of Science ®Google Scholar
• Salem A, Hope W. Absorption of morphine from a slow-release emulsion used to induce morphine dependence in rats. J Pharmacol Toxicol Methods 1998;40:159-64
   PubMed Web of Science ®Google Scholar
• Trotta M. Influence of phase transformation on indomethacin release from microemulsions. J Control Release 1999;60:399-405
   PubMed Web of Science ®Google Scholar
• Ren X, Svirskis D, Alany RG, et al. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery. Int J Pharm 2012;431:130-7
   PubMed Web of Science ®Google Scholar
• Nakhare S, Vyas SP. Preparation and characterization of multiple emulsion based systems for controlled diclofenac sodium release. J Microencapsul 1996;13:281-92
   PubMed Web of Science ®Google Scholar
• He L, Wang GL, Zhang Q. An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile. Int J Pharm 2003;250:45-50
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Lambert KJ, Tustian AK, et al. Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm Res 2000;17:175-82
   PubMed Web of Science ®Google Scholar
• Wang JJ, Sung KC, Hu OY, et al. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release 2006;115:140-9
   PubMed Web of Science ®Google Scholar
• Ma S, Chen F, Ye X, et al. Intravenous microemulsion of docetaxel containing an anti-tumor synergistic ingredient (Brucea javanica oil): formulation and pharmacokinetics. Int J Nanomedicine 2013;8:4045-52
   PubMed Web of Science ®Google Scholar
• Kang BK, Chon SK, Kim SH, et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm 2004;286:147-56
   PubMed Web of Science ®Google Scholar
• Assumpção JU, Campos ML, Ferraz Nogueira Filho MA, et al. Biocompatible microemulsion modifies the pharmacokinetic profile and cardiotoxicity of doxorubicin. J Pharm Sci 2013;102:289-96
   PubMed Web of Science ®Google Scholar
• Park KM, Kim CK. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int J Pharm 1999;181:173-9
   PubMed Web of Science ®Google Scholar
• Zhang T, Zheng Y, Peng Q, et al. A novel submicron emulsion system loaded with vincristine-oleic acid ion-pair complex with improved anticancer effect: in vitro and in vivo studies. Int J Nanomedicine 2013;8:1185-96
   PubMed Web of Science ®Google Scholar
• Lutz O, Meraihi Z, Mura JL, et al. Fat emulsion particle size: influence on the clearance rate and the tissue lipolytic activity. Am J Clin Nutr 1989;50:1370-81
   PubMed Web of Science ®Google Scholar
• Olivecrona G, Olivecrona T. Clearance of artificial triacylglycerol particles. Curr Opin Clin Nutr Metab Care 1998;1:143-51
   PubMedGoogle Scholar
• Deanesly R, Parkes AS. Note on the subcutaneous absorption of oils by rats and mice, with special reference to the assay of œstrin. J Physiol 1933;78:155-60
   PubMedGoogle Scholar
• Gupta S, Moulik SP, Lala S, et al. Designing and testing of an effective oil-in-water microemulsion drug delivery system for in vivo application. Drug Deliv 2005;12:267-73
   PubMed Web of Science ®Google Scholar
• Fouad SA, Basalious EB, El-Nabarawi MA, et al. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int J Pharm 2013;453:569-78
   PubMed Web of Science ®Google Scholar